Stay updated on Pembrolizumab Combo in Ovary Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Ovary Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Ovary Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    2%
    Check dated 2025-10-06T07:55:49.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Added a new reference for Nivolumab plus ipilimumab in advanced melanoma and updated the page version to v3.1.0; removed a closely related Genetics Information Center entry and older version, effectively replacing the reference with an updated citation. Overall, bibliographic updates with minor versioning, no other substantive content changes.
    Difference
    0.5%
    Check dated 2025-09-29T04:31:28.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1; the 'Back to Top' element has been removed.
    Difference
    0.1%
    Check dated 2025-09-14T21:56:58.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.1%
    Check dated 2025-09-07T19:08:43.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, as well as the introduction of new terms related to ovarian cancer and various chemical compounds. Notably, the previous version's references to ovarian epithelial cancer and several antineoplastic agents have been removed.
    Difference
    2%
    Check dated 2025-08-31T12:30:40.000Z thumbnail image
  8. Check
    52 days ago
    Change Detected
    Summary
    The reference to the study 'Nivolumab plus ipilimumab in advanced melanoma' has been completely removed from the page.
    Difference
    0.2%
    Check dated 2025-08-24T09:16:39.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Ovary Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Ovary Cancer Clinical Trial page.